Open Access Library Journal 2023, Volume 10, e9580 ISSN Online: 2333-9721 ISSN Print: 2333-9705 DOI: 10.4236/oalib.1109580 Jan. 20, 2023 1 Open Access Library Journal Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of Congo Berry Bongenya Ikolango 1,2 , Mariano Lusakibanza 3 , Gauthier Mesia Kahunu 3 , Baudoin Buassa Bu Tsumbu 4 , Richard Kalala Lunganza 4 , Erick Kamangu Ntambwe 2,4* 1 Faculty of Medicine, Bel Campus Technological University, Kinshasa, Democratic Republic of Congo 2 “HIV/AIDS Focus” Research Group, Kinshasa, Democratic Republic of Congo 3 Clinical Pharmacology Unit, Department of Pharmacology, Faculty of Medicine and Pharmaceutical Sciences, University of Kinshasa, Kinshasa, Democratic Republic of Congo 4 Service of Molecular Biochemistry, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo Abstract Background: Anemia remains the most frequent hematological complication during HIV/AIDS infection. Objective: The objective of this study was to de- termine the prevalence of anemia among People Living with HIV (PLHIV) who start AntiRetroViral treatment in Kinshasa in the era of Dolutegravir. Methods: This study was a descriptive cross-sectional study to determine the prevalence of anemia in PLHIV at the start of ARV Treatment (ART) in 13 Outpatient Treatment Centers (OTC) in Kinshasa. The patient inclusion pe- riod was from October 04, 2021 to February 15, 2022. Patients included in the present study were HIV type 1 infected, ART naïve, over the age of 18 and had signed informed consent for participation. The parameters of interest were: The hemoglobin level and the clinic of the patients. Results: One hun- dred and nineteen patients were included in this work with an average age of 39.87 ± 12.36 years and extremities of 18 to 69 years. The most represented age group is that of 36 to 45 years with 37 patients (31.9%). Sixty-seven pa- tients (56.3%) are female. The average value for Hemoglobin is 10.30 ± 2.33 g/dl. The most represented range of values is that of more than 13 g/dl with 73 patients (69.5%). Forty-nine (49) patients, or 41.5%, were in clinical stage 3. Fifty-five (55) patients, or 47.0%, had normal clinical status. Conclusion: How to cite this paper: Ikolango, B.B., Lusakibanza, M., Kahunu, G.M., Tsumbu, B.B.B., Lunganza, R.K. and Ntambwe, E.K. (2023) Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kin- shasa, Democratic Republic of Congo. Open Access Library Journal, 10: e9580. https://doi.org/10.4236/oalib.1109580 Received: November 16, 2022 Accepted: January 17, 2023 Published: January 20, 2023 Copyright © 2023 by author(s) and Open Access Library Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access